¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"malignant melanoma: gallium imaging"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • malignant fibrous histiocytoma
    ¾Ç¼º¼¶À¯Á¶Á÷±¸Á¾
  • malignant hidradenoma
    ¾Ç¼º¶¡»ùÁ¾
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾Ð
  • malignant hyperthermia
    ¾Ç¼º°í¿­
  • malignant mesothelioma
    ¾Ç¼ºÁßÇÇÁ¾
  • malignant myopia
    ¾Ç¼º±Ù½Ã
  • malignant smallpox
    ¾Ç¼º¸¶¸¶
  • malignant teratoma
    ¾Ç¼º±âÇüÁ¾
  • malignant transformation
    ¾Ç¼ºÀüȯ
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • neuroleptic malignant syndrome
    ½Å°æÀÌ¿ÏÁ¦¾Ç¼ºÁõÈıº
  • adjunctive imaging technique
    º¸Á¶¿µ»ó±â¹ý
  • cine magnetic resonance imaging
    ¿µÈ­ÀÚ±â°ø¸í¿µ»ó
  • chemical shift imaging
    È­Çк¯À§¿µ»ó
  • dynamic imaging
    ¿ªµ¿¿µ»ó, µ¿¿µ»ó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • malignant cholera
    ¾Ç¼ºÄÝ·¹¶ó
  • malignant degeneration
    ¾Ç¼ºº¯¼º
  • malignant reticulemic erythroderma
    ¾Ç¼º¸Á»óÈ«»öÇǺÎÁõ
  • malignant hidradenoma
    ¾Ç¼º¶¡»ùÁ¾
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾Ð
  • malignant hyperthermia
    ¾Ç¼º°í¿­
  • malignant fibrous histiocytoma
    ¾Ç¼º¼¶À¯Á¶Á÷±¸Á¾
  • malignant progressive histiocytoma
    ¾Ç¼ºÁøÇàÁ¶Á÷±¸Á¾
  • malignant
    ¾Ç¼º-
  • malignant acanthosis nigricans
    ¾Ç¼ºÈæ»ö°¡½Ã¼¼Æ÷Áõ
  • malignant myopia
    (¢¡degenerative myopia) º¯¼º±Ù½Ã
  • malignant smallpox
    ¾Ç¼º¸¶¸¶
  • malignant teratoma
    ¾Ç¼º±âÇüÁ¾
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • adjunctive imaging technique
    º¸Á¶ ¿µ»ó ±â¹ý
  • advanced Fourier imaging
    Áøº¸ Fourier ¿µ»ó
  • fractional echo imaging
    ºÐÇÒ ¿¡ÄÚ ¿µ»ó
  • frequency modulation imaging
    Á֯ļö º¯Á¶ ¿µ»ó
  • functional brain imaging
    ±â´ÉÀû ³ú¿µ»ó
  • functional magnetic resonance imaging (fMRI)
    ±â´ÉÀû ÀÚ±â°ø¸í¿µ»ó
  • gradient refocused imaging
    °æ»ç ÀçÃÊÁ¡ ¿µ»ó
  • half Fourier imaging
    ¹Ý Fourier ¿µ»ó
  • hybrid imaging
    È¥¼º ¿µ»ó
  • imaging
    »ó»ó,¿µ»ó
  • imaging
    ¿µ»ó
  • imaging gradient
    ¿µ»ó °æ»ç(ÀÚ°è)
  • imaging modality
    ¿µ»ó±â¹ý
  • imaging of STIR sequence
    STIR ¿¬¼â ¿µ»ó
  • imaging parameter
    ¿µ»ó ÁöÇ¥, ¿µ»ó º¯¼ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • juvenile melanoma
    ¿¬¼Ò¼º Èæ»öÁ¾(¡­ýÙßäðþ)
  • juvenile melanoma
    ¿¬¼Ò¼º Èæ»öÁ¾(¡­ýÙßäðþ).
  • lentigo maligna melanoma
    ¾Ç¼ºÈæÀÚ Èæ»öÁõ
  • lentigo maligna melanoma
    ¾Ç¼ºÈæÁ¡ÀÚÈæ»öÁ¾(äÂàõýÙïÇí­ýÙßäðþ)
  • malignat hereditary melanoma
    ¾Ç¼º À¯Àü¼º Èæ»öÁ¾
  • melanoma
    Èæ»öÁ¾
  • melanoma
    Èæ»öÁ¾(ýÙßäðþ)
  • melanoma in situ
    ¿øÀ§Ä¡Èæ»öÁ¾
  • melanoma iridis
    È«Ã¤Èæ»öÁ¾
  • melanoma of choroid
    ¸Æ¶ô¸·Èæ»öÁ¾
  • melanosis circumscripta precancerosa => lentigo maligna melanoma
  • melanotic whitlow => subungual melanoma
    ÇǺÎ,º´¸®
  • metastatic melanoma
    ÀüÀ̼ºÈæ»öÁ¾
  • nevocytic melanoma
    ¸ð¹Ý¼¼Æ÷¼º Èæ»öÁ¾
  • nodular melanoma
    °áÀý¼º Èæ»öÁ¾(~ýÙßäðþ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • chemical shift imaging [=CSI]
    È­ÇÐÀûº¯À§¿µ»ó
  • cine cardiac magnetic resonance imaging
    ¿µÈ­½ÉÀåÀÚ±â°ø¸í¿µ»ó
  • color flow imaging
    »öÇ÷·ù¿µ»ó
  • diagnostic imaging
    Áø´ÜÀû¿µ»ó, ¿µ»óÁø´Ü
  • diffusion imaging
    È®»ê¿µ»ó
  • diffusion tensor imaging [=DTI]
    È®»êÅÙ¼­¿µ»ó
  • diffusion weighted imaging [=DWI]
    È®»ê°­Á¶¿µ»ó
  • dynamic imaging
    ¿ªµ¿Àû¿µ»ó
  • echo planar imaging [=EPI]
    ¿¡ÄÚÆò¸é¿µ»ó
  • electrocardiograpic gated magnetic resonance imaging
    ½ÉÀüµµµ¿±âÀÚ±â°ø¸í¿µ»ó
  • fast Fourier imaging
    °í¼ÓFourier¿µ»ó
  • fast imaging technique
    °í¼Ó¿µ»ó±â¹ý
  • fast imaging with steady state precession [=FISP]
    Ç×Á¤»óż¼Â÷¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó¿µ»ó
  • fast scan imaging
    °í¼Ó½ºÄµ¿µ»ó
  • fast spin echo imaging
    °í¼Ó½ºÇÉ¿¡ÄÚ¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MMSP malignant melanoma of soft parts
NM near-miss; neomycin; neuromedin; neuromuscular; neutrophil migration; nictitating membrane; nitrogen...
NMM nodular malignant melanoma
167Ga radioactive Gallium(used in whole-body & brain scans)
Ga gallium; granulocyte agglutination
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Ga Gallium
GaAs Gallium arsenide
GA-67 Gallium-67
ALM Acral lentiginous melanoma
A-Mel-3 Amelanotic melanoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • malignant
    ¾Ç¼º, ¾Ç¼ºÀÇ
    Á¡Â÷ÀûÀ¸·Î ³ªºüÁ®¼­ Á×À½¿¡ À̸£°Ô ÇÏ´Â. ÅðÇ༺ ħÀ±, ÀüÀÌÀÇ ¼ºÁúÀ» °¡Áö´Â Á¾¾ç¿¡ »ç¿ëµÈ´Ù.
  • malignant adenoma
    ¾Ç¼º ¼±Á¾
  • malignant anthrax
    ¾Ç¼º źÀú
  • malignant cachexia
    ¾Ç¼º ¾Ç¾×Áú
  • malignant carcinoid tumor
    ¾Ç¼º Ä«¸£½Ã³ëÀ̵å Á¾¾ç
  • malignant degeneration
    ¾Ç¼ºÈ­
  • malignant external otitiis
    ¾Ç¼º ¿ÜÀÌ¿°
    ´ç´¢º´ ȯÀÚ³ª ¿©·¯ °¡Áö ¿øÀÎÀ¸·Î ¸é¿ª Àå¾Ö ȯÀڵ鿡¼­ ¿ÜÀ̵µ¿°ÀÌ ÁøÇàµÇ¾î µÎ°³ÀúÀÇ °ñ¼ö¿°¿¡ À̸£°Ô µÇ´Âµ¥ À̸¦ ¾Ç¼º ¿ÜÀÌ¿°À̶ó ÇÑ´Ù. ¿øÀαÕÀº Pseudomonas aeruginosaÀÌ¸ç ¿ÜÀ̵µÀÇ ¹Ù´Ú ºÎÀ§¿¡¼­ ±â½ÃÇÏ¿© Áߵΰ³Àú¿Í clivus, ½ÉÁö¾î´Â ¹Ý´ëÂÊÀÇ µÎ°³Àú¿¡ À̸£±âµµ ÇÑ´Ù. ȯÀÚµéÀº ´ë°³ ¾ÇÃë°¡ ³ª´Â ÀÌ·ç¿Í ÇÔ²² ¿ÜÀ̵µ¿¡´Â À°¾ÆÁ¶Á÷ÀÌ °üÂûµÇ°í ±íÀº ºÎÀ§ÀÇ ÀÌÅëÀ» È£¼ÒÇÑ´Ù. Áø´ÜÀº CT ÃÔ¿µÀ̳ª, ¹æ»ç¼± µ¿À§¿ø¼Ò¸¦ ÀÌ¿ëÇÑ °ñ ÁÖ»ç
  • malignant granuloma
    ¾Ç¼º À°¾ÆÁ¾
    ¾Ç¼º ¸²ÇÁÁ¾, º£°Ô³Ê À°¾ÆÁ¾°ú ´Ù¸£Áö¸¸ ±× º´ ÀÚü°¡ ¹àÇôÁöÁö ¾Ê¾Æ Á¾¾ç ¿©ºÎ Á¶Â÷µµ È®½ÇÇÏÁö ¾ÊÀºµ¥, ±«»ç¼º º´º¯ÀÌ ³Ê¹« °­ÇϹǷΠº´¸®Á¶Á÷ÇÐÀû °Ë»öµµ °ï¶õÇÏ´Ù. Àü½Å¼º ÀüÀÌ´Â ÀûÀ¸³ª ±¹¼ÒÀû ±«»ç ÁøÇàÀÌ ´ë´ÜÈ÷ ºü¸£°í ¼¼±Õ °¨¿°À» ÀÏÀ¸Å°±â ½¬¿ì¸ç ÆÐÇ÷Áõ°ú À¯»çÇÑ °£Çæ ¿­°ú °í¿­ÀÌ ÀϾ Àü½ÅÀÌ ¼è¾àÇØÁö°í ¿¹Èİ¡ ³ª»Ú´Ù.
  • malignant hemocytoblastoma
    ¾Ç¼º Ç÷±¸¸ð¼¼Æ÷Á¾
  • malignant hyperthermia
    ¾Ç¼º °í¿­Áõ, ¾Ç¼º °í¿­
    ¸¶Ãë Áß¿¡ °©ÀÚ±â °í¿­À» ³»°í »ç¸Á·üÀÌ ±ØÈ÷ ³ôÀº ÁõÈıº¿¡ ´ëÇÏ¿© À̸§ÀÌ ºÙ¿©Áø °ÍÀÌ´Ù. Áõ»óÀº È£ÈíÀ̳ª ¸Æ¹ÚÀÌ »¡¶óÁö°í ü¿ÂÀº 5ºÐ¿¡ 1¡É Á¤µµÀÇ ¼Óµµ·Î 42¡É¿¡³ª ´ÞÇÑ´Ù. µ¿½Ã¿¡ ±ÙÀÇ °æÁ÷À̳ª °ú±äÀåÀÌ »ý±â°í ´ë»ç¼º ¹× È£Èí¼º »êÁõ, °íÄ®·ýÇ÷ÁõÀÌ ³ªÅ¸³­´Ù. ±Ù°æÁ÷¼º À§Ãà, À¯ÀüÀÚ ÀÎÀÚ
  • malignant hyperthermia syndrome
    ¾Ç¼º °í¿­ ÁõÈıº
  • malignant lesion
    ¾Ç¼º º´¼Ò
  • malignant mesenchymoma
    ¾Ç¼º ³»¹è¿±Á¾
  • malignant myopia
    ¾Ç¼º ±Ù½Ã
    Ã༺ ±Ù½Ã·Î¼­ ¾ÈÃàÀåÀÌ ±¼Àý·Â¿¡ ºñÇØ ³Ê¹« ±æ¾î ÆòÇà ±¤¼±ÀÌ ¸Á¸· ¾Õ¿¡ ÃÊÁ¡À» ¸ÎÀ¸¹Ç·Î ¼±¸íÇÏÁö ¾ÊÀº »óÀ» ¸Î°Ô µÈ´Ù. °úµµÇÑ Á¶Àý ¹× ´« ¸ðÀ½, ½Ã½Å°æ À¯µÎÀÇ ºÎÁ¾, ³»ºÐºñ ÀÌ»ó, Æí½Ä µîÀÌ ¿øÀÎÀ̶ó°í ÇÏ´Â ÁÖÀåµµ ÀÖÀ¸³ª ºÐ¸íÄ¡ ¾Ê´Ù.
  • malignant neoplasm
    ¾Ç¼º ½Å»ý¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
gallium: indications <radiology> Indications: inflammation, bone, tumour, lung, renal, lymphoma, malignant melanoma NO UPTAKE: most benign neoplasms, haemangioma, cirrhosis, cystic disease of breast, liver, thyroid, reactive lymphadenopathy, inactive granulomatous disease see: gallium-67 citrate
(12 Dec 1998)
gallium isotopes Stable gallium atoms that have the same atomic number as the element gallium, but differ in atomic weight. Ga-71 is a stable gallium isotope.
(12 Dec 1998)
gallium radioisotopes Unstable isotopes of gallium that decay or disintegrate emitting radiation. Ga atoms with atomic weights 63-68, 70 and 72-76 are radioactive gallium isotopes.
(12 Dec 1998)
gallium uptake with normal chest film <radiology> Pulmonary drug toxicity, tumour infiltration, sarcoidosis, pneumocystis carinii see: lung: gallium imaging
(12 Dec 1998)
gallium vs. indium <radiology> Advantages: Ga-67 citrate, readily available, no preparation, bone and soft-tissue infections, chronic inflammatory processes, In-111 WBCs, no bowel uptake, minimal or no uptake in healing wounds, images easier to interpret, high specificity for inflammatory process
(12 Dec 1998)
acral lentiginous melanoma <tumour> A form of malignant lentigo melanoma that occurs in acral areas not excessively exposed to sunlight and where hair follicles are absent.
(05 Mar 2000)
amelanotic melanoma <tumour> An anaplastic melanoma consisting of cells derived from melanocytes but not forming melanin.
(05 Mar 2000)
benign juvenile melanoma A benign, slightly pigmented or red superficial small skin tumour composed of spindle-shaped, epithelioid, and multinucleated cells that may appear atypical; most common in children, but also appearing in adults.
Synonym: benign juvenile melanoma, epithelioid cell nevus, spindle cell nevus.
(05 Mar 2000)
cancer, melanoma A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. It can be cured if detected early, before spread (metastasis) to other areas. Diagnosis is confirmed by a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma.
(12 Dec 1998)
melanoma <oncology, tumour> A tumour arising from the melanocytic system of the skin and other organs. When used alone the term refers to malignant melanoma.
(18 Nov 1997)
melanoma, amelanotic An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin.
(12 Dec 1998)
melanoma growth stimulatory activity Cytokine of the C X C subfamily. Potent mitogen. Activates and is chemotactic for, neutrophils.
(18 Nov 1997)
minimal deviation melanoma <dermatology, tumour> A malignant melanoma showing less cytologic atypia than is usual in melanoma cells showing asymmetric expansile invasion of the dermis.
(05 Mar 2000)
Cloudman melanoma <tumour> A transplantable melanoma that arose spontaneously in a mouse of DBA strain, and which grows and metastasizes in mice of related strains.
(05 Mar 2000)
halo melanoma <tumour> A rare condition in which a melanoma is surrounded by an irregular area of depigmentation.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á